Byam Rebecca's Form 4 filing
HCW Biologics Inc. (HCWB) · filed Jun 8, 2023
- Accession no.
- 0001209191-23-035581
- Filed
- Jun 8, 2023
- Trade date
- Jun 7-8, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $51.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Byam RebeccaCIK 0001866256 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | Common Stock | PPurchaseAcquired | +20,000 | $2.03 | +$40,600 | 519,250 | Direct | |
| Jun 8, 2023 | Common Stock | PPurchaseAcquired | +4,696 | $2.21 | +$10,378.16 | 523,946 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.